Are We More Than Our DNA?
David Harrison
To what extent does DNA determine who we are? Prof David Harrison the
Director of Cancer Research, University of Edinburgh investigates.
Downloads
Resolution: 480 x 320 (MP4) (right click to download)
Professor David Harrison
Title/Position: John Reid Chair of Pathology (University of St. Andrews), Honorary Chair (University of Edinburgh)
Type of staff member: Associated Principal Investigator
Research Theme: Tissue Remodelling and Regeneration
Research Programme(s): Inflammation and Cancer
Research Group(s): Solid tumour models
Background:
David Harrison has recently joined the University of St Andrews as
Professor of Pathology, with an honorary chair at the University of
Edinburgh. He is Director of Laboratory Medicine for Lothian NHS, and
Designated Individual for Tissue Governance in Lothian. His clinical
expertise is in medical liver, kidney and transplant pathology and he
contributes to the diagnostic service of the Scottish National Liver
Transplant Programme. His research interests are varied, but are based
upon understanding how cells and tissue respond to injury. He is
Director of the Edinburgh Breakthrough Breast Cancer Research Unit in
Edinburgh and has an honorary Professorship in Medicinal Chemistry in
the University of Florida. He is also Chair of Medical Research
Scotland, Deputy Chair of the Food Standards Agency Committee on
Toxicity, trustee of the Melville Trust, board and audit committee
member of the Office of the Scottish Charity Regulator, a member of the
National Cancer Research Institute Biomarkers & Imaging Clinical
Studies Group, member of the Funds Advisory Committee of the Edinburgh
& Lothian Health Foundation, board member of the Scottish Life
science Association and a member of the European Food Standards Agency
Expert Working Group on Aspartame.
Honorary Professor: David Harrison
David Harrison has been made an Honorary Professor in the College of Medicine and Veterinary Medicine.
Professor Harrison joined the University of St Andrews as Professor of Pathology in May.
He leaves his role as Professor of Pathology in the University of Edinburgh which he has held since 1998.
He
is Director of Laboratory Medicine for Lothian NHS, overseeing more
than 600 staff working in pathology, genetics, biochemistry and
haematology.
He is also Designated Individual for Tissue Governance in Lothian.
Professor Harrison’s clinical expertise is in medical liver, kidney and transplant pathology.
He
continues to contribute to the diagnostic service of the Scottish
National Liver Transplant Programme, including on-call commitments.
His
research interests are varied but based upon understanding how cells
and tissue respond to injury. He works with chemists in Edinburgh on
hypoxia and mass spectrometry imaging, work that will continue through
St Andrews.
He is Director of the Edinburgh Breakthrough Breast
Cancer Research Unit, and formerly Director of the Edinburgh
Experimental Cancer Medicine Centre.
Professor Harrison has an
honorary Professorship in Medicinal Chemistry in the University of
Florida where he is part of an award winning distance learning team.
He
is chair of Medical Research Scotland, Deputy Chair of the Food
Standards Agency Committee on Toxicity, and a member of the European
Food Standards Agency Expert Working Group on Aspartame.
This article was published on Aug 17, 2012
